Showing results (21-30 of 419) with videos related to
Sort By:
Pageof 42
International Seminars in Surgical Oncology : ISSO|December 3, 2005
Tattoo pigment in an axillary lymph node simulating metastatic malignant melanomaC M Jack, A Adwani, H KrishnanEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Desmoid tumours treated with triphenylethylenesM D Brooks, S R Ebbs, A A Colletta, et al.European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Lymphatic relapse in women with early breast cancer: a difficult management problemF McKinna, L Gothard, S Ashley, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1989
The Cancer Research Campaign trials of adjuvant therapy for early breast cancerM Baum, S R Ebbs, J Houghton, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1990
The design of advanced breast cancer trials. New approachesS C Fraser, S R Ebbs, H J Dobbs, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1993
Trial of aminoglutethimide vs hydrocortisone as second-line hormone treatment of advanced breast cancerP M Mercer, S R Ebbs, S C Fraser, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Advanced breast cancer. A randomised trial of epidoxorubicin at two different dosages and two administration systemsS R Ebbs, J A Saunders, H Graham, et al.The West Indian Medical Journal|November 20, 2012
Report and viewpoint on the Vaccine Safety Conference, Tryall Club, Jamaica, January 3-7, 2011: cautionary tales and implications for the CaribbeanS LoweEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Side-effects of screeningI W Garstin, Z Kaufman, M J Michell, et al.British Journal of Cancer|February 1, 1993
Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of lifeS C Fraser, H J Dobbs, S R Ebbs, et al.Pageof 42